Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Psyched Wellness Ltd PSYCF


Primary Symbol: C.PSYC

Psyched Wellness Ltd. is a Canada-based health supplements company. The Company is engaged in the distribution of mushroom-derived products and associated consumer packaged goods. The Company creates organic, natural, and lab-tested mushroom products to promote health and wellness of people globally. The Company is in the process of developing a line of Amanita muscaria-derived water-based extracts, teas, and capsules. Amanita muscaria helps to reduce stress, ease muscular tension, and promote restorative sleep. The Company's wholly owned subsidiary is Psyched Wellness Corp.


CSE:PSYC - Post by User

Psyched Wellness Ltd > Commencement of Next Pre-Clinical Study on AME-1
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(271)
•••
Comment by InvestABCson Oct 07, 2021 10:46am
132 Views
Post# 33979721

RE:Commencement of Next Pre-Clinical Study on AME-1

RE:Commencement of Next Pre-Clinical Study on AME-1here we go...

ANON to ANON has been going on for a long time in 500 blocks, seen this pattern before.....

ITS GO TIME!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities